Antianxiety Treatments and Human Memory

  • H. V. Curran


In this chapter I shall focus on pharmacological treatments of anxiety — on how anxiolytic drugs affect human cognitive functions. Little is known about the effects of non-pharmacological treatments of anxiety, although it is possible that any effective anti-anxiety treatment may influence cognition by changing how threat-related information is attended to and interpreted. Within pharmacological treatments, the benzodiazepines (BDZ) have attracted by far the widest research effort and interest in terms of their effects on memory. It is widely reported that BDZ produce anterograde ‘amnesia’ in humans. Many studies have been carried out in which a single dose of a BDZ has been given to non-anxious, volunteer subjects and significant impairments have been found in their performance on memory tasks. Indeed, anaesthetists often praise the ‘amnesic’ action of BDZ. When these drugs are given as premedicants before an operation, the patient is likely to forget the entire experience and anaesthetists see this as an advantage. Clearly, for the many thousands of patients who take BDZ on a daily basis as an antianxiety treatment, memory loss is a definite disadvantage.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Atkinson, R. C. and Shiffrin, R. M. (1971). The control of short-term memory. Sci. Amer., 225, 82–90.PubMedCrossRefGoogle Scholar
  2. Baddeley, A. D. and Hitch, G. (1974). Working memory. In Bower, G. H. (ed.). The Psychology of Learning and Motivation, vol. 8, Academic Press, London, 47–90.Google Scholar
  3. Bennett-Levy, J. and Powell, G. E. (1980). The subjective memory questionnaire (SMQ). An investigation into the self-reporting of ‘real-life’ memory skills. Br. J. Clin. Psychol., 19, 177–88.CrossRefGoogle Scholar
  4. Birch, B. and Curran, H. V. (1990). The differential effects of flumazenil on the psychomotor and amnesic actions of midazolam. J. Psychopharmacol., 4, 29–34.PubMedCrossRefGoogle Scholar
  5. Brown, M. W., Brown, J. and Bowes, J. (1989). Absence of priming coupled with substantially preserved recognition in lorazepam induced amnesia. Quart. J. Exp. Psychol., 599–617.Google Scholar
  6. Brown, J., Lewis, V., Brown, M. W., Horn, G. and Bowes, J. B. (1982). A comparison between transient amnesias induced by two drugs (diazepam and lorazepam) and amnesia of organic origin. Neuropsychologia, 20, 55–70.PubMedCrossRefGoogle Scholar
  7. Curran, H. V. (1986). Tranquillising memories: a review of the effects of benzodiazepines on human memory. Biol. Psychol., 23, 179–213.PubMedCrossRefGoogle Scholar
  8. Curran, H. V., Schifano, F. and Lader, M. (submitted). Models of memory dysfunction? A comparison of the effects of scopolamine and lorazepam on memory, psychomotor performance and mood, Psychopharmacology, in press.Google Scholar
  9. Curran, H. V., Schiwy, W., Eves, F., Shine, P. and Lader, M. (1988). A ‘levels of processing’ study of the effects of benzodiazepines on human memory. Hum. Psychopharmacol., 3, 21–5.CrossRefGoogle Scholar
  10. Curran, H. V., Schiwy, W. and Lader, M. (1987). Differential amnesic properties of benzodiazepines: a dose response comparison of two drugs with similar elimination half-lives. Psychopharmacology, 92, 358–64.PubMedCrossRefGoogle Scholar
  11. Danion, J.-M., Zimmermann, M.-A., Willard-Schroeder, D., Grange, D. and Singer, L. (1989). Diazepam induces a dissociation between explicit and implicit memory. Psychopharmacology, 99, 238–43.PubMedCrossRefGoogle Scholar
  12. Dorow, R., Berenberg, D., Duka, T. and Sauergrey, N. (1987). Amnesic effects of lormetazepam and their reversal by the benzodiazepine antagonist Ro 15-1788. Psychopharmacology, 93(4), 507–14.PubMedCrossRefGoogle Scholar
  13. Fang, J. C., Hinrichs, J. V. and Ghoneim, M. M. (1987). Diazepam and memory: evidence for spared memory function. Pharmacol. Biochem. Behav., 28, 347–52.PubMedCrossRefGoogle Scholar
  14. Gentil, V., Taveres, S., Gorenstein, C., Bello, C., Mathias, L., Gronich, G. and Singer, J. (1990). Acute reversal of flunitrazepam effects by Ro 15-1788 and Ro 153505: inverse antagonism, tolerance, and rebound. Psychopharmacology, 100, 54–9.PubMedCrossRefGoogle Scholar
  15. Ghoneim, M. M., Dembo, J. B. and Block, R. I. (1989). Time course of antagonism of sedative and amnesic effects of diazepam by flumazenil. Anesthesiology, 70, 899–904.PubMedCrossRefGoogle Scholar
  16. Ghoneim, M. M., Hinrichs, J. V. and Mewaldt, S. P. (1984). Dose-response analysis of the behavioural effects of diazepam. I: Learning and memory. Psychopharmacology, 82, 291–5.PubMedCrossRefGoogle Scholar
  17. Ghoneim, M. M., Mewaldt, S. P., Berie, J. L. and Hinrichs, V. (1981). Memory and performance effects of single and 3 weeks administration of diazepam. Psychopharmacology, 73, 147–51.PubMedCrossRefGoogle Scholar
  18. Golombok, S., Moodley, P. and Lader, M. (1988). Cognitive impairment in long-term benzodiazepine users. Psychol. Med., 18, 365–74.PubMedCrossRefGoogle Scholar
  19. Haefely, W. (1985). Tranquillisers. In Grahame-Smith, D. G. and Cowen, P. J. (eds), Psychopharmacology, 2, Part 1, Preclinical Psychopharmacology, Elsevier, Amsterdam, 92–182.Google Scholar
  20. Hinrichs, J. V., Ghoneim, M. M. and Mewaldt, S. P. (1984). Diazepam and memory: retrograde facilitation produced by interference reduction. Psychopharmacology, 84, 158–62.PubMedCrossRefGoogle Scholar
  21. Hommer, D. W., Breier, A., Paul, S. M., Davis, M. and Weingartner, H. (1986). Ro 15-1788, a specific benzodiazepine antagonist, blocks the sedative, anxiolytic and attentional but not the amnestic effects of diazepam in humans. Abstracts of the 25th ACNP Annual Meeting in Washington.Google Scholar
  22. Lister, R. G. and File, S. E. (1984). The nature of lorazepam-induced amnesia. Psychopharmacology, 83, 183–7.PubMedCrossRefGoogle Scholar
  23. Lucki, I., Rickels, K. and Geller, A. M. (1986). Chronic use of benzodiazepines and psychomotor and cognitive test performance. Psychopharmacology, 88, 426–33.PubMedCrossRefGoogle Scholar
  24. Mathews, A. (1988). Anxiety and the processing of threatening information. In Hamilton, V., Bower, G. H. and Frijda, N. H. (eds), Behavioral and Social Sciences, vol. 44, Cognitive Perspectives on Emotion and Motivation, Kluwer, Dordrecht, 265–84.Google Scholar
  25. Mewaldt, S. P., Hinrichs, J. V. and Ghoneim, M. M. (1983). Diazepam and memory: support for a duplex model of memory. Mem. Cognit., 11, 557–64.PubMedCrossRefGoogle Scholar
  26. Morre, M., Bachy, A. and Keane, P. E. (1985). Differential CNS binding of benzodiazepines. Supplément Actualités Médicales Internationales — Psychiatrie, 2, 28–32.Google Scholar
  27. Morton, S. and Lader, M. H. (1990). Studies with alpidem in normal volunteers and anxious patients. Pharmacopsychiatry, 23, 120–3.PubMedCrossRefGoogle Scholar
  28. O’Boyle, C., Lambe, R., Darragh, A., Taffe, W., Brick, I. and Kenny, M. (1983). RO 15-1788 antagonizes the effects of diazepam in man without affecting its bioavailability. Br. J. Anaesth., 55, 349–55.PubMedCrossRefGoogle Scholar
  29. Tulving, E. (1985). How many memory systems are there? Amer. Psychol., 40, 385–98.CrossRefGoogle Scholar
  30. Weingartner, H. (1985). Models of memory dysfunctions. Am. NY Acad. Sci., 444, 359–69.CrossRefGoogle Scholar
  31. Weingartner, H. and Wolkowitz, O. M. (1988). Pharmacological strategies for exploring psychobiologically distinct cognitive systems. Psychopharmacology, 96 (suppl.), S125.Google Scholar

Copyright information

© Macmillan Publishers Limited 1991

Authors and Affiliations

  • H. V. Curran
    • 1
  1. 1.Department of PsychiatryInstitute of PsychiatryLondonUK

Personalised recommendations